Skip to main content

Medications for Gastric Cancer

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Keytruda 1.0 5 reviews for Keytruda to treat Gastric Cancer
Rx D N
Generic name:
pembrolizumab systemic
Drug class:
anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
pembrolizumab 1.0 5 reviews for pembrolizumab to treat Gastric Cancer
Rx D N
Generic name:
pembrolizumab systemic
Brand name:
Keytruda
Drug class:
anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
methotrexate Off-label 1.0 1 review for methotrexate to treat Gastric Cancer
Rx X N X
Generic name:
methotrexate systemic
Drug class:
antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
Cyramza Rate Add review
Rx C N
Generic name:
ramucirumab systemic
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
docetaxel Rate Add review
Rx D N
Generic name:
docetaxel systemic
Brand name:
Taxotere
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Enhertu Rate Add review
Rx N
Generic name:
fam-trastuzumab deruxtecan systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
fam-trastuzumab deruxtecan Rate Add review
Rx N
Generic name:
fam-trastuzumab deruxtecan systemic
Brand name:
Enhertu
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Herceptin Rate Add review
Rx D N
Generic name:
trastuzumab systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Kanjinti Rate Add review
Rx D N
Generic name:
trastuzumab systemic
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Lonsurf Rate Add review
Rx N
Generic name:
tipiracil / trifluridine systemic
Drug class:
antineoplastic combinations
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Ogivri Rate Add review
Rx D N
Generic name:
trastuzumab systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Ontruzant Rate Add review
Rx D N
Generic name:
trastuzumab systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
ramucirumab Rate Add review
Rx C N
Generic name:
ramucirumab systemic
Brand name:
Cyramza
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Taxotere Rate Add review
Rx D N
Generic name:
docetaxel systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
tipiracil / trifluridine Rate Add review
Rx N
Generic name:
tipiracil / trifluridine systemic
Brand name:
Lonsurf
Drug class:
antineoplastic combinations
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
trastuzumab Rate Add review
Rx D N
Generic name:
trastuzumab systemic
Brand names:
Ogivri, Herceptin, Trazimera, Kanjinti, Ontruzant
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Trazimera Rate Add review
Rx D N
Generic name:
trastuzumab systemic
Drug class:
HER2 inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.